Liye Wang Selected Research

Liye Wang Research Topics

Disease

13	Neoplasms (Cancer) 11/2023 - 06/2011
5	Breast Neoplasms (Breast Cancer) 01/2023 - 01/2021
4	Chronic Obstructive Pulmonary Disease (COPD) 05/2023 - 01/2021
3	Neoplasm Metastasis (Metastasis) 11/2021 - 11/2019
2	Human Influenza (Influenza) 05/2023 - 10/2022
2	Lung Neoplasms (Lung Cancer) 11/2021 - 01/2020
2	Inflammation (Inflammations) 07/2020 - 11/2019
2	Colorectal Neoplasms (Colorectal Cancer) 07/2020 - 11/2019
2	Colonic Neoplasms (Colon Cancer) 07/2020 - 03/2020
2	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2014 - 01/2014
1	Osteosarcoma (Osteogenic Sarcoma) 11/2023
1	Tertiary Lymphoid Structures 01/2023
1	COVID-19 10/2022
1	Pneumonia (Pneumonitis) 10/2022
1	Microsatellite Instability 12/2021
1	Pneumococcal Infections 04/2021
1	Coccidiosis 01/2021
1	Diarrhea 01/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Infections 01/2021
1	Thrombocytopenia (Thrombopenia) 01/2021
1	Virus Diseases (Viral Diseases) 01/2021
1	Ovarian Neoplasms (Ovarian Cancer) 03/2020
1	Edema (Dropsy) 01/2020
1	Ischemic Stroke 01/2018
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2018
1	Communicable Diseases (Infectious Diseases) 01/2017
1	Thinness 03/2016
1	Tuberculosis (Tuberculoses) 01/2016
1	Sleep Deprivation 01/2014
1	AIDS-Related Complex (ARC) 01/2014
1	Sleep Wake Disorders 01/2014
1	Pathologic Constriction (Stenosis) 05/2012
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 06/2011

Drug/Important Bio-Agent (IBA)

3	Influenza Vaccines (Influenza Vaccine)FDA Link 05/2023 - 01/2021
3	23-valent pneumococcal capsular polysaccharide vaccineIBA 05/2023 - 04/2021
2	VaccinesIBA 10/2022 - 04/2021
2	Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA 10/2022 - 04/2021
2	Fluorescent Dyes (Fluorescent Probes)IBA 01/2021 - 09/2020
2	Long Noncoding RNAIBA 03/2020 - 11/2019
2	Biomarkers (Surrogate Marker)IBA 03/2020 - 11/2019
2	CholesterolIBA 05/2012 - 06/2011
1	Circular RNAIBA 11/2023
1	Polysaccharides (Glycans)IBA 05/2023
1	HydrogelsIBA 01/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022
1	VemurafenibIBA 01/2022
1	ParaffinIBA 12/2021
1	Formaldehyde (Formol)FDA Link 12/2021
1	Proteins (Proteins, Gene)FDA Link 11/2021
1	PlectinIBA 11/2021
1	PeptoidsIBA 11/2021
1	PeptidomimeticsIBA 11/2021
1	ErbB Receptors (EGF Receptor)IBA 01/2021
1	diaveridineIBA 01/2021
1	rofecoxib (Vioxx)FDA Link 01/2021
1	Alanine Transaminase (SGPT)IBA 01/2021
1	Transaminases (Aminotransferases)IBA 01/2021
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021
1	Epidermal Growth Factor (EGF)IBA 01/2021
1	Hormones (Hormone)IBA 01/2021
1	Muramidase (Lysozyme)IBA 01/2021
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2021
1	TransferasesIBA 01/2021
1	pyrazoleIBA 09/2020
1	Coloring Agents (Dyes)IBA 09/2020
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 09/2020
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 09/2020
1	Celecoxib (Celebrex)FDA Link 09/2020
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 07/2020
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 07/2020
1	CateninsIBA 07/2020
1	Calcitriol (Calcijex)FDA LinkGeneric 03/2020
1	Vitamin D FDA LinkGeneric 03/2020
1	MicellesIBA 01/2020
1	Benzene (Benzole)IBA 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	Messenger RNA (mRNA)IBA 11/2019
1	Competitive Endogenous RNAIBA 11/2019
1	MicroRNAs (MicroRNA)IBA 11/2019
1	Xinnao ShutongIBA 01/2018
1	Neuroprotective AgentsIBA 01/2018
1	Adenosine Diphosphate (ADP)IBA 01/2017
1	ractopamineIBA 03/2016
1	Adrenergic Agents (Adrenergic Drugs)IBA 03/2016
1	QuinoxalinesIBA 01/2016
1	GhrelinIBA 01/2014
1	Peptides (Polypeptides)IBA 01/2014
1	deoxynivalenolIBA 01/2014
1	Radioisotopes (Radionuclides)IBA 01/2014
1	wendanIBA 01/2014
1	LeptinIBA 01/2014
1	OrexinsIBA 01/2014

Therapy/Procedure

6	Therapeutics 01/2022 - 06/2011
3	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2014 - 06/2011
1	Immunotherapy 01/2023
1	Complementary Therapies (Alternative Medicine) 01/2021
1	Neoadjuvant Therapy 01/2021
1	Drug Therapy (Chemotherapy) 01/2020
1	Cutaneous Administration 01/2020